| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −0.7× | −1.7× | |
| Price / Book | 8.8× | 2.0× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −0.8× | −1.6× | |
| EV / EBITDA | −0.7× | −1.2× | |
| Earnings yield | −136.7% | −14.3% | |
| Free cash flow yield | −125.7% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,284.57 | +3.57% | $1.21T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.11 | +2.10% | $624.43B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $286.44 | +1.33% | $506.17B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $414.98 | +1.99% | $372.48B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.14 | +3.14% | $365.49B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.50 | +1.53% | $281.13B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $167.27 | +2.03% | $259.42B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $683.24 | +0.57% | $252.63B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $430.76 | +1.37% | $232.88B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.04 | +1.94% | $193.48B | 22.3× | 37.5% | +29.9% |
